CJC-1295 No DAC is a synthetic peptide that operates on the GHRH Pathway. CJC-1295 stimulates the pituitary gland to naturally produce and release growth hormone. Unlike exogenous human growth hormone (HGH) injections that replace your body’s natural production, CJC-1295 No DAC acts as a secretagogue—meaning it prompts your body to pulse and secrete its own hormone improving downstream biological effects.

Benefits (Research Focus)

• GHRH receptor agonism — studied for selective stimulation of the GHRH receptor and pituitary GH release
• Pulsatile GH release — investigated for physiologic-pattern growth hormone release versus sustained DAC variant
• IGF-1 axis signaling — explored for downstream hepatic IGF-1 production and somatotropic endpoints
• DPP-IV resistance — examined for extended pharmacokinetic profile via four amino acid substitutions
• Combination pharmacology — researched alongside GHS-R agonists (e.g., ipamorelin, MK-677) for paired pathway studies

⚠️ Disclaimer

• This product is intended for laboratory research use only.
• Not for human or veterinary use.
• Not approved for diagnostic, therapeutic, or medical applications.
• Handle using appropriate laboratory safety procedures and personal protective equipment.